Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
18
currently held
Exits tracked
6
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin21 companies matching
HTBA
Miura Fund III
Sector
Pharma
InvestorMiura Partners
Entry
2019
Hold
6yr
Owners
2
Nuzoa
PAI Mid-Market Fund
Sector
Pharma
InvestorPAI Partners
Entry
2020
Hold
5yr
Owners
2
Natac Group
Stellum Food & Tech I
Sector
Pharma
InvestorStellum Capital
Entry
2021
Hold
3yr
Owners
2
Diater
Fondo Nazca Small Cap I
Sector
Pharma
InvestorNazca Capital
Entry
2019
Hold
4yr
Exit
2023
to WORG Pharma
Curapath
Columbus Innvierte Life Science Fund I
Sector
Pharma
InvestorColumbus Venture Partners
Entry
2017
Hold
4yr
Exit
2021
to Arcline Investment Management
Idifarma
Sodena Direct
Sector
Pharma
InvestorSodena
Entry
2006
Hold
15yr
Exit
2021
to Ardena
Ojer Pharma
Easo Ventures II
Sector
Pharma
InvestorEaso Ventures
Entry
2014
Hold
12yr
Owners
2
3P Biopharmaceuticals
Eurazeo Private Debt V
Sector
Pharma
InvestorEurazeo
Entry
2019
Hold
7yr
Advanthera
Columbus Life Sciences Fund IV
Sector
Pharma
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Cuantum Medical Cosmetics
Inveready Biotech II
Sector
Pharma
InvestorInveready Asset Management
Entry
2015
Hold
11yr
Farmalider
MCH Iberian Capital Fund V
Sector
Pharma
InvestorMCH Private Equity Investments
Entry
2023
Hold
3yr
IRAB
MED Rise
Sector
Pharma
InvestorARCHIMED
Entry
2026
Hold
0yr
Linneo Health
Torreal
Sector
Pharma
InvestorTorreal
Entry
2018
Hold
8yr
Medical Plants
Realza Capital Fund II
Sector
Pharma
InvestorRealza Capital
Entry
2021
Hold
5yr
Noucor
MCH Iberian Capital Fund V
Sector
Pharma
InvestorMCH Private Equity Investments
Entry
2022
Hold
4yr
Rioja Nature Pharma
Tresmares Private Equity Fund II
Sector
Pharma
InvestorTresmares Capital
Entry
2023
Hold
3yr
Unolab Manufacturing
ProA Capital Iberian Buyout Fund II
Sector
Pharma
InvestorProA Capital
Entry
2016
Hold
10yr
Alcala Farma
Latin American Private Equity Fund VII
Sector
Pharma
InvestorAdvent International
Entry
–
Laboratorios Ovejero
ADE Capital Sodical
Sector
Pharma
InvestorSodical
Entry
2018
Hold
8yr
Montplet
Corpfin Capital Fund VI
Sector
Pharma
InvestorCorpfin Capital
Entry
2025
Hold
1yr
Vivunt Pharma
ADE Capital Sodical
Sector
Pharma
InvestorSodical
Entry
2022
Hold
4yr